April 19, 2026 CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)
April 19, 2026 Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
April 19, 2026 Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Round
